ORIGINAL RESEARCH
Accepted on 17 Jan 2025
Safety assessment of rosuvastatin-fenofibrate combination in the treatment of hyperlipidemia based on FDA's Adverse Event Reporting System Database
doi 10.3389/fphar.2025.1415701
3,003
Total downloads
11k
Total views and downloads
You will be redirected to our submission process.
ORIGINAL RESEARCH
Accepted on 17 Jan 2025
ORIGINAL RESEARCH
Accepted on 17 Jan 2025
ORIGINAL RESEARCH
Accepted on 27 Dec 2024
ORIGINAL RESEARCH
Published on 11 Nov 2024
ORIGINAL RESEARCH
Published on 29 Oct 2024
ORIGINAL RESEARCH
Published on 28 Aug 2024
ORIGINAL RESEARCH
Published on 09 Aug 2024
ORIGINAL RESEARCH
Published on 20 Jun 2024
ORIGINAL RESEARCH
Published on 19 Jun 2024
ORIGINAL RESEARCH
Published on 21 Feb 2024
ORIGINAL RESEARCH
Published on 21 Feb 2024